ciamexon has been researched along with Diabetes Mellitus, Type 1 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beales, PE; Cartledge, C; Krug, J; Lampeter, EF; Pozzilli, P; Procaccini, E; Signore, A; Williams, AJ | 1 |
Diamantstein, T; Hahn, HJ; Knospe, S; Köhler, E; Roemer, KG | 1 |
Bicker, U; Herz, M; Schmeidl, R; Schwedes, U; Teuber, J; Usadel, KH | 1 |
Beyer, J; Hogan, M; Schrezenmeier, J; Stuermer, W; Weber, P | 1 |
Bicker, U; Usadel, KH | 1 |
Bicker, U; Kiesel, U; Kolb, H; Maruta, K; Treichel, U | 1 |
6 other study(ies) available for ciamexon and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Immunotherapy with ciamexon in the non obese diabetic (NOD) mouse.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Aziridines; Diabetes Mellitus, Type 1; Female; Glycosuria; Immunoglobulin G; Male; Mice; Mice, Inbred NOD; Sheep | 1992 |
Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antibody-Dependent Cell Cytotoxicity; Aziridines; Azirines; Chromium Radioisotopes; Diabetes Mellitus, Type 1; Humans; Islets of Langerhans; Monocytes; Rats; Rats, Inbred Strains | 1989 |
Management of type I diabetes with ciamexone.
Topics: Adolescent; Adult; Aziridines; Azirines; Diabetes Mellitus, Type 1; Female; Humans; Male; Pilot Projects | 1986 |
Influence of ciamexon on blood glucose and insulin requirement in newly manifested type I diabetics. Results of a pilot study.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Viral; Autoantibodies; Aziridines; Azirines; Blood Glucose; C-Peptide; Chemical Phenomena; Chemistry; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male | 1988 |
Ciamexone, a highly selective immunomodulator--a tool for autoimmune diseases?
Topics: Antibody Formation; Arthritis, Rheumatoid; Autoimmune Diseases; Aziridines; Azirines; Diabetes Mellitus, Type 1; Humans; T-Lymphocytes | 1986 |
Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.
Topics: Aging; Animals; Aziridines; Azirines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Leukocytes; Male; Rats; Rats, Inbred BB; Sex Factors | 1986 |